DK2091537T3 - Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati - Google Patents

Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati

Info

Publication number
DK2091537T3
DK2091537T3 DK07846885.7T DK07846885T DK2091537T3 DK 2091537 T3 DK2091537 T3 DK 2091537T3 DK 07846885 T DK07846885 T DK 07846885T DK 2091537 T3 DK2091537 T3 DK 2091537T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical compositions
capillary arteriopathy
arteriopathy
capillary
Prior art date
Application number
DK07846885.7T
Other languages
English (en)
Inventor
Rudolf Reiter
Johannes Tack
Reinhard Horowski
Original Assignee
Sinoxa Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinoxa Pharma Gmbh filed Critical Sinoxa Pharma Gmbh
Application granted granted Critical
Publication of DK2091537T3 publication Critical patent/DK2091537T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07846885.7T 2006-11-23 2007-11-23 Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati DK2091537T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06024308 2006-11-23
EP06025263 2006-12-06
PCT/EP2007/010360 WO2008061805A1 (de) 2006-11-23 2007-11-23 Pharmazeutische zusammensetzungen zur behandlung von kapillarer arteriopathie

Publications (1)

Publication Number Publication Date
DK2091537T3 true DK2091537T3 (da) 2013-08-26

Family

ID=38982525

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07846885.7T DK2091537T3 (da) 2006-11-23 2007-11-23 Farmaceutiske sammensætninger til behandlingen af kapillær arteriopati

Country Status (14)

Country Link
US (2) US20090325997A1 (da)
EP (1) EP2091537B1 (da)
JP (1) JP5407865B2 (da)
AU (1) AU2007324706B2 (da)
CA (1) CA2670846C (da)
CY (1) CY1114364T1 (da)
DK (1) DK2091537T3 (da)
ES (1) ES2425581T3 (da)
HR (1) HRP20130791T1 (da)
PL (1) PL2091537T3 (da)
PT (1) PT2091537E (da)
RU (1) RU2463048C2 (da)
SI (1) SI2091537T1 (da)
WO (1) WO2008061805A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2550959A1 (de) * 2011-07-27 2013-01-30 Sinoxa Pharma Lisurid, Tergurid und Derivate davon zur Verwendung in der Prophylaxe und/oder Therapie fibrotischer Veränderungen
DE102010051391A1 (de) 2010-11-11 2012-10-11 Sinoxa Pharma Ug Multivalente Arzneistoffe mit kombinierter antioxidativer Wirkung und antagonistischen Effekten an 5-HT2-Rezeptor-Subtypen zur Behandlung von fibrotischem Organumbau.
US20140058108A1 (en) * 2010-11-11 2014-02-27 Sinoxa Pharma Ug Lisuride, Terguride and Derivatives Thereof for Use in the Prophylaxis and/or Treatment of Fibrotic Changes
RU2516921C1 (ru) * 2013-04-08 2014-05-20 Общество с ограниченной ответственностью "Научно-производственная компания ВИТАФОРМ" Композиция для костной пластики (варианты)
JP6856532B2 (ja) 2015-01-20 2021-04-07 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ エルゴリン化合物およびその使用
CN109843297A (zh) * 2016-10-20 2019-06-04 辉瑞大药厂 治疗pah的抗增殖剂
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
WO2023107931A1 (en) * 2021-12-06 2023-06-15 Terran Biosciences, Inc. Salt and solid forms of indole analogs and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
JP2005508220A (ja) * 2001-10-24 2005-03-31 パーリ・ゲーエムベーハー 薬用組成物調製用具
US20070149451A1 (en) * 2003-11-17 2007-06-28 Holmes David G Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
EP1900737A1 (en) * 2006-08-31 2008-03-19 Novartis AG Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US20140058108A1 (en) * 2010-11-11 2014-02-27 Sinoxa Pharma Ug Lisuride, Terguride and Derivatives Thereof for Use in the Prophylaxis and/or Treatment of Fibrotic Changes

Also Published As

Publication number Publication date
JP5407865B2 (ja) 2014-02-05
RU2009123401A (ru) 2010-12-27
US20140045879A1 (en) 2014-02-13
WO2008061805A1 (de) 2008-05-29
EP2091537B1 (de) 2013-05-22
US20090325997A1 (en) 2009-12-31
AU2007324706A2 (en) 2009-06-25
CY1114364T1 (el) 2016-08-31
AU2007324706B2 (en) 2013-09-05
EP2091537A1 (de) 2009-08-26
PL2091537T3 (pl) 2013-10-31
AU2007324706A1 (en) 2008-05-29
JP2010510273A (ja) 2010-04-02
SI2091537T1 (sl) 2013-10-30
PT2091537E (pt) 2013-08-29
RU2463048C2 (ru) 2012-10-10
CA2670846C (en) 2014-12-23
US9695173B2 (en) 2017-07-04
ES2425581T3 (es) 2013-10-16
CA2670846A1 (en) 2008-05-29
HRP20130791T1 (en) 2013-09-30

Similar Documents

Publication Publication Date Title
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK3354276T3 (da) Sammensætninger til behandlingen af gastrointestinal inflammation
DK1928405T3 (da) Farmaceutiske sammensætninger til behandling af indre øreforstyrrelser
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2046264T3 (da) Fremgangsmåder til fremstillingen af sammensætninger med film
BRPI0719393A2 (pt) Composição farmacêutica
DK2063868T3 (da) Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium
DK2137537T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK2041139T3 (da) Farmaceutiske forbindelser
DK2034830T3 (da) Anti-vla-1-antistof til behandling af slagtilfælde
DK1868579T3 (da) Farmaceutisk sammensætning omfattende en omega-carboxyaryl sunstitueret diphenylurea til behandling af cancer
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
BRPI0720234A2 (pt) Composição farmacêutica
DK2216021T3 (da) Farmaceutisk sammensætning til behandling af overaktiv blære
DK3300743T3 (da) Fremgangsmåder til indgivelse af vaccine
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2010184T3 (da) Implatanter til behandlingen af dopamin associerede tilstande
DK2079577T3 (da) Fremgangsmåde til fremstilling af fodtøj
DK1987817T3 (da) Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme